Frequently asked questions

It unifies various therapeutic approaches into a logic focused on life, connection, and the present moment.

The virus persists in our bodies, much like herpes. It reactivates during times of physical or emotional stress, causing either chronic inflammatory symptoms or occasional acute flare-ups. Its role has changed: it now reveals our vulnerabilities. It’s no longer about defeating it, but drawing new strength from it. Learning to live with it means choosing conscious life — and rethinking our relationship to health and others.

This negative perception comes from a dominant medical model in which disease is seen as the primary cause of symptoms. In that view, symptoms are consequences of an invisible condition (“underlying disease”) that must be identified and treated at the root — otherwise, treating only the symptoms would be like turning off a warning light without fixing the engine.

But this logic rests on a questionable assumption: that disease always precedes symptoms. In a different paradigm — where symptoms come first and signal early imbalance — a well-conducted symptomatic treatment becomes a form of prevention. It intervenes before misalignment or degeneration becomes irreversible.

The perspective we choose determines the value we assign to symptom treatment: either it masks a hidden illness (classical view), or it intercepts a process still in motion (reformed view).

The word “accompaniment” puts the person at the center. It’s not about “fixing” dysfunctions as conventional treatments often try to do — urgently. Instead, it supports a unique path of transformation for each being.

Yes — if illness is understood as the body’s attempt to regain balance. Then healing becomes possible, but follows a different path than symptom suppression.

It’s a fresh, external perspective on your situation, beyond conventional medical pathways. It doesn’t replace your physician — it broadens the reflection.

The patient is no longer a passive object, but an active subject: they listen, understand, act, and choose. They become a co-creator of their own health.

A diagnosis is not always necessary to begin accompaniment. Listening to signs and personal experience often opens the right path.

This is the view of homeopathy, which selects remedies based on what is strange, rare, or curious in the patient’s symptoms. Hahnemann even said: “Where is the disease if the patient has no more symptoms?” These unusual symptoms reveal the patient’s unique way of creating their world — while official disease categories ignore them in favor of a standard, common world shaped for the many.

Aspirin is often labeled as a symptomatic treatment due to its analgesic and antipyretic effects. However, it also acts at a deeper level: it slows down clot formation, modulates inflammatory pathways, and even—in low doses—inhibits certain metabolic cascades linked to cell degeneration.

Several studies have shown that it can reduce the risk of heart attack, stroke, and even certain cancers when administered preventively and in a targeted manner.

It thus illustrates the potential of symptomatic treatment to become a tool for fine-tuning regulation, at the crossroads between the immediate and the structural.

It triggers mitochondrial dysfunction, oxidative stress, DNA fragmentation, and cell death — clearly pro-inflammatory (PubMed).
It’s also harmful for brain development: “Nearly 20 lines of evidence (animal studies, human observation, timing correlations, pharmacologic analysis) suggest that infant exposure to acetaminophen causes most autism spectrum disorders, with increased risk in postpartum use.” (PubMed)

Even adult brains are affected: “Acetaminophen reduces emotional reactivity by dampening brain areas related to emotion. A double-blind study shows that 1,000 mg lowers both personal pleasure and positive empathy toward others, revealing a neurochemical link between pain relief and affective flattening.” (PubMed)

A dangerous challenge spreading on platforms like TikTok: the “Paracetamol challenge” encourages teens to take large doses of paracetamol (e.g. Doliprane or Dafalgan) to test their resistance — often ending in hospitalization. First seen in the US in summer 2023, it’s now spreading in Europe. (francebleu.fr)